TP53 and neoplasm: This complicated interplay between p53 and the microbiome is further exemplified by the recent finding that, in particular regions of the gut, bacteria-released gallic acid can actively switch mutant p53 function from tumour-suppressive to oncogenic by interfering with its ability to abrogate Wnt signalling [131].